Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
Clinical trial NCT03428126 · COMPLETED
Trial details
- NCT number
- NCT03428126
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2022-05-05
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.